Marpai, Inc.

Equities

MRAI

US5713542083

Software

Market Closed - Nasdaq 04:30:00 2024-04-26 pm EDT 5-day change 1st Jan Change
2.18 USD +2.35% Intraday chart for Marpai, Inc. -6.44% +24.57%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Marpai, Inc. Announces Executive Appointments CI
Marpai, Inc. announced that it has received $11.83 million in funding from JGB Management Inc. CI
Maxim Upgrades Marpai to Buy From Hold, Price Target is $6 MT
Transcript : Marpai, Inc., Q4 2023 Earnings Call, Mar 27, 2024
Marpai, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Marpai Insider Bought Shares Worth $1,501,500, According to a Recent SEC Filing MT
Marpai, Inc. announced that it expects to receive $1.5015 million in funding CI
Marpai, Inc. Provides Impairment Guidance for the Fourth Quarter of 2023 CI
Marpai, Inc. Announces Off-Cycle New Client Agreement CI
Marpai, Inc. announced that it has received $1.7 million in funding from Libertas Funding, LLC CI
Top Premarket Gainers MT
Marpai Insider Bought Shares Worth $1,012,110, According to a Recent SEC Filing MT
Marpai, Inc. announced that it expects to receive $1.216464 million in funding CI
Marpai, Inc. Appoints John Powers as President CI
PayFlex Systems USA, Inc. acquired Maestro Health Consumer Directed Benefits Business of Marpai, Inc.. CI
Marpai, Inc. announced that it expects to receive $0.2955 million in funding CI
Marpai, Inc. Announces Board Changes CI
Transcript : Marpai, Inc. - Special Call
Sector Update: Tech Stocks Higher Late Afternoon MT
Sector Update: Tech MT
Top MIdday Gainers MT
Marpai Insider Bought Shares Worth $123,000, According to a Recent SEC Filing MT
North American Morning Briefing : Stock Futures -2- DJ
North American Morning Briefing : Stocks Seen -2- DJ
Maxim Downgrades Marpai to Hold From Buy MT
Chart Marpai, Inc.
More charts
Marpai, Inc. is a technology-driven healthcare company, which uses artificial intelligence (AI) and data analytics. The Company provides administrative services and acts as a third-party administrator (TPA) to self-insured employers who provide healthcare benefits to their employees. Its products and services include Health Plan Administration services, Ancillary In-House services, and Third-Party Vendor services. Its Health Plan Administration services offering includes handling all aspects of administration related to a healthcare plan. Its In-House Ancillary Services are derived from its in-house products related to its role as the administrator of the clients' health plans. The Company typically design healthcare benefit plan for its client, which allows the client to define the coverage it would like to provide to its employees. The Company offers MarpaiRx, a national pharmacy benefit management program.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.18 USD
Average target price
6 USD
Spread / Average Target
+175.23%
Consensus